• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Second-generation drug-eluting stents and the continuous need for rapidly available real-world data.

作者信息

Mukherjee Debabrata, Moliterno David J

出版信息

JACC Cardiovasc Interv. 2009 Dec;2(12):1236-9. doi: 10.1016/j.jcin.2009.10.010.

DOI:10.1016/j.jcin.2009.10.010
PMID:20129550
Abstract
摘要

相似文献

1
Second-generation drug-eluting stents and the continuous need for rapidly available real-world data.第二代药物洗脱支架以及对快速可得的真实世界数据的持续需求。
JACC Cardiovasc Interv. 2009 Dec;2(12):1236-9. doi: 10.1016/j.jcin.2009.10.010.
2
Drug-eluting stents: more dollars than sense?药物洗脱支架：性价比高吗？
JACC Cardiovasc Interv. 2009 Dec;2(12):1188-9. doi: 10.1016/j.jcin.2009.11.001.
3
Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions).恩多雷药物洗脱支架与雷帕霉素洗脱依维莫司药物洗脱支架（Xience V）对比的 4 年临床与经济长期分析：来自 ENDEAVOR II 试验的结果（评价美敦力 AVE ABT-578 依维莫司洗脱驱动冠状动脉支架在初发原生冠状动脉病变中应用的安全性和有效性的随机对照试验）
JACC Cardiovasc Interv. 2009 Dec;2(12):1178-87. doi: 10.1016/j.jcin.2009.10.011.
4
Drug-eluting stents: safe but not sufficient.药物洗脱支架：安全但并不足够。
JACC Cardiovasc Interv. 2009 Jun;2(6):513-4. doi: 10.1016/j.jcin.2009.04.002.
5
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).恩多雷佐塔鲁利姆洗脱支架与西罗莫司洗脱支架的长期临床和经济分析：来自 ENDEAVOR III 试验的 3 年结果（美敦力恩多雷药物[ABT-578]洗脱冠状动脉支架系统与西罗莫司洗脱冠状动脉支架系统在初发原生冠状动脉病变中的随机对照试验）。
JACC Cardiovasc Interv. 2009 Dec;2(12):1199-207. doi: 10.1016/j.jcin.2009.10.009.
6
Intravascular ultrasound optimization of drug-eluting stents: still not enough data.药物洗脱支架的血管内超声优化：数据仍不充足。
Catheter Cardiovasc Interv. 2010 Mar 1;75(4):584-5. doi: 10.1002/ccd.22488.
7
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.会议报告：2007年9月27 - 28日于尼斯欧洲心脏之家举行的欧洲心脏病学会药物洗脱支架论坛
EuroIntervention. 2009 Jan;4(4):427-36.
8
Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a 'real-world' comparison among patients with diabetes with diffuse small vessel coronary artery disease.冠状动脉裸金属支架与药物洗脱支架植入后的长期预后：糖尿病合并弥漫性小血管冠状动脉疾病患者的“真实世界”比较
Coron Artery Dis. 2011 Mar;22(1):96-9. doi: 10.1097/MCA.0b013e32834236d0.
9
Cost-effectiveness of the Endeavor stent in de novo native coronary artery lesions updated with contemporary data.采用当代数据更新的新型 Endeavor 支架治疗初发原生冠状动脉病变的成本效益分析。
EuroIntervention. 2010 Feb;5(7):826-32. doi: 10.4244/eijv5i7a138.
10
Drug-eluting stents for ST-segment elevation myocardial infarction: treatment of choice or is discretion the better part of valor?
JACC Cardiovasc Interv. 2008 Jun;1(3):233-5. doi: 10.1016/j.jcin.2008.04.001.

引用本文的文献

1
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.比较佐他莫司洗脱支架和依维莫司洗脱支架治疗冠状动脉疾病患者的12个月试验的临床结果：来自THCRIC注册研究的数据。
Ther Adv Cardiovasc Dis. 2016 Aug;10(4):206-13. doi: 10.1177/1753944716629868. Epub 2016 Feb 7.
2
Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients.第二代或第三代药物洗脱支架植入后对临床稳定患者进行常规随访冠状动脉造影的临床影响。
Korean J Intern Med. 2015 Jan;30(1):49-55. doi: 10.3904/kjim.2015.30.1.49. Epub 2014 Dec 30.
3
A Randomized Comparison between Everolimus-Eluting Stent and Cobalt Chromium Stent in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Using Routine Intravenous Eptifibatide: The X-MAN (Xience vs. Multi-Link Stent in Acute Myocardial Infarction) Trial, A Pilot Study.
在接受直接经皮冠状动脉介入治疗并常规静脉使用依替巴肽的急性ST段抬高型心肌梗死患者中，依维莫司洗脱支架与钴铬合金支架的随机对照研究：X-MAN（急性心肌梗死中Xience与Multi-Link支架对比）试验，一项初步研究。
Int J Angiol. 2014 Jun;23(2):93-100. doi: 10.1055/s-0033-1356649.
4
Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents.比较第一代和第二代药物洗脱支架的光学相干断层成像评估。
Yonsei Med J. 2012 May;53(3):524-9. doi: 10.3349/ymj.2012.53.3.524.
5
[Second-generation DES : New, but also cost-effective?].[第二代药物洗脱支架：新，但也具有成本效益？]
Herz. 2011 May;36(3):254-61. doi: 10.1007/s00059-011-3463-2.
6
TWENTE Study: The Real-World Endeavor Resolute Versus Xience V Drug-Eluting Stent Study in Twente: study design, rationale and objectives.TWENTE 研究：特温特真实世界 RESOLUTE 与 Xience V 药物洗脱支架研究：研究设计、原理和目标。
Neth Heart J. 2010 Aug;18(7-8):360-4. doi: 10.1007/BF03091792.